๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Augmentation of lymphokine-activated killer cell activity in patients with gastrointestinal cancer

โœ Scribed by P. C. Sedman; C. W. Ramsden; T. G. Brennan; G. R. Giles; Mr. P. J. Guillou

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
602 KB
Volume
75
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Lymphokine-activated killer cell and nat
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
โœ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 499 KB ๐Ÿ‘ 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr

Inducible lymphokine-activated killer (L
Inducible lymphokine-activated killer (LAK) cell activity in the peripheral blood of patients with relapsed/refractory non-Hodgkin's lymphoma (NHL)
โœ Kenneth W. Zamkoff; Nora P. Watman; David B. Duggan; Bernard J. Poiesz; Arlan J. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 453 KB

Therapy with recombinant interleukin-2 (rIL-2) induces clinical response in a significant number of patients with refractory malignant disease. Very few patients with non-Hodgkin's lymphoma (NHL) have been treated with rIL-2. The present study sought to determine if peripheral blood mononuclear cell